Therefore we aimed to test (a) whether GDF-15 concentrations were a predictor of liver fibrosis and potentially involved in the association between T2DM and liver fibrosis and (b) what factors linked with T2DM are independently associated with, and explain the variance in GDF-15 concentrations, in patients with NAFLD. The gene discussed is GDF15; the disease is Hepatic fibrosis.